What is CVE-2023-42666?

CVE-2023-42666 is a medium-severity vulnerability in Dexma Dexgate, classified under Information Disclosure. CVSS score: 5.3/10. Published 2023-10-19.

How severe is CVE-2023-42666?

Medium severity. CVSS v3 base score is 5.3 out of 10.

Information disclosure in Dexma Dexgate

CVE-2023-42666

The affected product is vulnerable to an exposure of sensitive information to an unauthorized actor vulnerability, which may allow an attacker to create malicious requests for obtaining the information of the version about the web server used.

Vulnerability class: Information Disclosure

EPSS: 0.004 (30.9th percentile) — read the EPSS interpretation.

CVSS v3 metric

CVSS v3 base score 5.3 (Medium). Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:N/A:N.

Affected products

Dexma Dexgate — versions 20130114, version 20130114

Weakness classification (CWE)

CWE-200 — Information Disclosure

References

ics-cert@hq.dhs.gov (US Government Resource, Third Party Advisory)

Frequently asked questions

What is CVE-2023-42666?: CVE-2023-42666 is a medium-severity vulnerability in Dexma Dexgate, classified under Information Disclosure. CVSS score: 5.3/10. Published 2023-10-19.
How severe is CVE-2023-42666?: Medium severity. CVSS v3 base score is 5.3 out of 10.